Clincosm LogoSign in Get a demo

Solid Tumor

Showing NaN - NaN of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)

Recruiting
  • Cancer
  • +11 more
  • San Antonio, Texas
    South Texas Accelerated Research Therapeutics, LLC
Jun 21, 2023

Solid Tumor Trial in San Antonio, Tyler, Spokane (TU2218 + Pembrolizumab)

Recruiting
  • Solid Tumor
  • TU2218 + Pembrolizumab
  • San Antonio, Texas
  • +2 more
Mar 26, 2023

Solid Tumor Trial in Huntersville, San Antonio (IGM-7354)

Recruiting
  • Solid Tumor
  • Huntersville, North Carolina
  • +1 more
Jan 25, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Solid Tumors, Adult, Solid Tumor, Mesothelioma (MPM) Trial in United States (IK-930)

Recruiting
  • Solid Tumors, Adult
  • +7 more
  • Boston, Massachusetts
  • +6 more
Jan 24, 2023

Cancer, Solid Tumor, Solid Carcinoma Trial in United States (AMXT1501, DFMO)

Active, not recruiting
  • Cancer
  • +3 more
  • Austin, Texas
  • +3 more
Jan 18, 2023

Solid Tumor Trial in United States (ASP3082)

Recruiting
  • Solid Tumor
  • Santa Monica, California
  • +10 more
Jan 6, 2023

Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily

Recruiting
  • Solid Tumor
  • +8 more
  • TPST-1495 twice daily
  • +2 more
  • Baltimore, Maryland
  • +8 more
Jan 4, 2023

Solid Tumor Trial in United States (ASTX295)

Recruiting
  • Solid Tumor
  • Duarte, California
  • +9 more
Nov 18, 2022

Metastatic Cancer, Solid Tumor, Lymphoma Trial in Canada, United States (Sym021, Sym022, Sym023)

Completed
  • Metastatic Cancer
  • +2 more
  • Grand Rapids, Michigan
  • +3 more
Oct 25, 2022

Solid Tumor Trial in United States (VT1021)

Active, not recruiting
  • Solid Tumor
  • Sarasota, Florida
  • +11 more
Oct 21, 2022

Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Canada, Spain, United States (BNT141,

Recruiting
  • Solid Tumor
  • +7 more
  • BNT141
  • +2 more
  • Duarte, California
  • +10 more
Aug 23, 2022

Solid Tumor, Metastatic Tumor, Locally Advanced Malignant Tumor Trial in United States (SNDX-6352, Durvalumab)

Completed
  • Solid Tumor
  • +3 more
  • Scottsdale, Arizona
  • +4 more
Aug 17, 2022

Hepatocellular Carcinoma, Solid Tumor, Hepatocellular Carcinoma Non-resectable Trial in San Antonio (OTX-2002, Tyrosine kinase

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • San Antonio, Texas
    Next Oncology
Aug 9, 2022

Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +8 more
Aug 8, 2022

Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors Trial in United States (MRTX1719)

Recruiting
  • Mesothelioma
  • +5 more
  • Denver, Colorado
  • +5 more
Aug 8, 2022

Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

Completed
  • Small Cell Lung Cancer
  • +7 more
  • Scottsdale, Arizona
  • +4 more
Jul 20, 2022

Solid Tumor, Microsatellite Instability-High (MSI-H) Solid Tumors, Cutaneous Melanoma Trial in Worldwide (LY3300054,

Active, not recruiting
  • Solid Tumor
  • +4 more
  • Nashville, Tennessee
  • +14 more
Jul 21, 2022

Solid Tumor Trial in United States (IDE397, Docetaxel, Paclitaxel)

Recruiting
  • Solid Tumor
  • Scottsdale, Arizona
  • +10 more
Jul 20, 2022

Solid Tumor Trial in Singapore, Spain, United States (BNT142)

Recruiting
  • Solid Tumor
  • BNT142
  • Los Angeles, California
  • +9 more
Jul 21, 2022

Solid Tumor Trial in Worldwide (PRS-344/S095012)

Recruiting
  • Solid Tumor
  • Huntersville, North Carolina
  • +10 more
Jun 29, 2022

Solid Tumor Trial in United States (ORIC-101, Nab-paclitaxel)

Active, not recruiting
  • Solid Tumor
  • Palo Alto, California
  • +11 more
Mar 22, 2022

Solid Tumor, CNS Tumor, Lymphoma Trial in Canada, United States (Neratinib)

Recruiting
  • Solid Tumor
  • +3 more
  • Phoenix, Arizona
  • +8 more
Mar 21, 2022

Metastatic Cancer, Solid Tumor, Cholangiocarcinoma Trial in United States (LYT-200, Anti-PD-1, Gemcitabine/nab-paclitaxel)

Recruiting
  • Metastatic Cancer
  • +4 more
  • Phoenix, Arizona
  • +15 more
Mar 9, 2022

Solid Tumor Trial in Italy, United States (Derazantinib low dose range, Derazantinib middle dose range, Derazantinib high dose

Completed
Has Results
  • Solid Tumor
  • Derazantinib low dose range
  • +3 more
  • Scottsdale, Arizona
  • +11 more
Mar 7, 2022